Treatment-resistant depression: therapeutic trends, challenges, and future directions

Cited by (794)

Items 601–700 of 794

1. The decrease in procoagulant activity of blood during combined therapy with antidepressants and antipsychotics in patients with endogenous mental disorders
   O.S. Brusov, N.S. Karpova, I.V. Oleichik, M.I. Faktor, S.V. Sizov · 2021 · S S Korsakov Journal of Neurology and Psychiatry
2. Dextroamphetamine-Amphetamine Augmentation in the Treatment of Treatment-Resistant Depression
   Tyler M. Small, Sanket Dhat, Zeeshan Faruqui · 2022 · Cureus
3. A Comparison between Single and Double-Dose Intravenous Ketamine Administration in Bipolar Mood Disorder: A Double-Blind Controlled Clinical Trial
   Ali Talaeı, Farhad Farid Hoseini, Meisam Mahdavi, Maryam Salehi, Asieh Karimani, Fahimeh Afzaljavan · 2023 · Iranian Journal of Psychiatry
4. Longitudinal Outcomes of Resilience, Quality of Life, and Community Integration in Treatment-Resistant Depression: A Two-Group Matched Controlled Trial
   Chia‐Yi Wu, Ming‐Been Lee, Phạm Thị Thu Hương, I‐Ming Chen, Hsi‐Chung Chen, Min-Hsien Hsieh · 2023 · Journal of the American Psychiatric Nurses Association
5. Real-world evidence from a European cohort study of patients with treatment resistant depression: Country-specific data for Portugal
   João Miguel Bessa, Gonçalo Cotovio, Orlando von Doellinger, Juliana Pierami de Freitas, Elvira Lara, Ana Matos-Pires, Madalena Serra, Gonçalo Amorim, A. Filipa Pereira, Albino Jorge Oliveira-Maia · 2024 · Journal of Affective Disorders Reports
6. Comparative Side‐Effects of Neurosurgical Treatment of Treatment‐Resistant Depression
   Alexandre Lim Eng Keat, Keith Tan Jian Li, Chuin Hau Teo, Tomoko Soga · 2024 · CNS Neuroscience & Therapeutics
7. Modulating neuroplasticity through synergistic ketamine and accelerated sequential theta burst stimulation (TBS) for treatment-resistant depression (TRD) – A case report
   Veena Ramesh, Varsha Shamanna, Harsh Pathak, Swarna Buddha Nayok, Anushree Bose, Vanteemar Sathyanarayana Sreeraj, Ganesan Venkatasubramanian · 2024 · Asian Journal of Psychiatry
8. LncRNA of peripheral blood mononuclear cells: HYMAI acts as a potential diagnostic and therapeutic biomarker for female major depressive disorder
   Tianyi Bu, Jiarun Yang, Jiawei Zhou, Yeran Liu, Kexin Qiao, Yan Wang, Jili Zhang, Erying Zhao, Boakye Kwame Owura, Xiaohui Qiu et al. · 2025 · Frontiers in Psychiatry
9. Magnesium, is it still playing a role in depression? – An insight from Kashmir
   Rajnish Raj, Junaid Nabi, Deeba Nazir, Zaid Ahmad Wani, Inaamul Haq, IfshanaIliyas Rather, Ulfat Majeed · 2024 · Journal of Medical Society
10. Physical activity, weekend catch-up sleep, and depressive symptoms: mediating effects of high-sensitivity C-reactive protein
    Sunyoung Kim, Soo In Kim, Weon‐Jeong Lim · 2025 · Journal of Affective Disorders
11. Treatment Approaches for Psychiatric and Cognitive Comorbidities in Pediatric Epilepsy: A Systematic Review of Clinical Trials
    Airin Parvin Nipu, Vinay Gundareddy, I. Raza, F. Hassan, Muhammad Mairaj, Zain Ullah, Kinza Binte Khalid, Diego Jiménez Royg, Mofiyinfoluwa O Oloba, Mmahaletchumy Manoharan et al. · 2025 · Cureus
12. Comparing the effects of ECT and intravenous ketamine in psychiatric patients with major depressive episodes
    Julia Myerson, Katrina A. Rufino, Sanjay J. Mathew, Marie Fletcher, Neil Puri, Hyuntaek Oh · 2025 · Journal of Affective Disorders
13. A randomized, double-blind, sham controlled clinical trial to evaluate the efficacy of electrical vestibular stimulation (VeNS) for major depressive disorder
    Sai Sailesh Kumar Goothy, Rohit Singh, Joseph Reel, Rachel Robinson, Wiktoria Ratajczak, Sinead Watson, Jason McKeown · 2025 · Journal of Affective Disorders
14. MicroRNAs as Biomarkers and Therapeutic Targets in Treatment- Resistant Depression: Unveiling Diagnostic and Treatment Pathways
    Alaa A. A. Aljabali, Almuthanna K. Alkaraki, Omar Gammoh, Esam Y. Qnais, Abdelrahim M. Alqudah, Walhan Alshaer, Vijay Kumar Mishra, Yachana Mishra, Mohamed El‐Tanani · 2025 · Current Clinical Pharmacology
15. Real-world esketamine treatment for treatment-resistant depression: an analysis of comorbid post-traumatic stress disorder, comorbid anxiety disorder and line of therapy subgroups
    Malcolm Hopwood, David Codyre, David Barton, Elizabeth M. Scott, Andrea Puig, Jarrad King, Ian Bernard Hickie · 2025 · Research Directions Depression
16. Amplitude of brain low-frequency fluctuation and functional connectivity changes based on fMRI study in first-episode major depressive disorder
    Yanting Zheng, Huai Tu, Danian Li, Jing Wang, Baohua Chen, Jie Zhou, Shijun Qiu, Yujie Liu · 2025 · Clinical Neurology and Neurosurgery
17. The psychedelic phenethylamine 25C-NBF, a selective 5-HT2A agonist, shows psychoplastogenic properties and rapid antidepressant effects in male rodents
    Núria Nadal‐Gratacós, Pol Puigseslloses, Laura Guzmán, Nicola Weiss, Eline Pottie, Clara Riera-Colomer, Virginie Lardeux, Nathalie Thiriet, Fu-Hua Wang, Liselott Källsten et al. · 2025 · Molecular Psychiatry
18. Personalized continuation therapy with SAINT for maintaining remission in treatment-resistant depression
    Katy H. Stimpson, Michael T. Feyder, Adi Maron‐Katz, Eren Kiris, Tiffany J. Ford, David M. Carreon, Danielle D. DeSouza, Eleanor J. Cole, Nathan F. Meng, Nolan Williams et al. · 2025 · Transcranial magnetic stimulation .
19. Self‐Processing Circuits Among Depressed Youth After Amygdala Neurofeedback Cued to the Self‐Face
    Sewon Oh, Niki Hosseini‐Kamkar, Carmen Santana‐Gonzalez, Janani Ranatunga, Giang‐Hoang Nguyen, Matthew Maurice, Kymberly D. Young, Karina M. Quevedo · 2025 · Journal of Neuroscience Research
20. An Experimental Study to Evaluate the Role of Buprenorphine, Morphine, and Naltrexone in Animal Models of Depression
    Nichwa Leuwenhoek Suja Nongtdu,, Veena Verma · 2025 · Cureus
21. Mental health professionals’ perspective on the use of esketamine in treatment-resistant depression and their motivation to adopt it: a Saudi cross-sectional study
    Ahmad H. Almadani, Ayedh H. Alghamdi, Gosay M. Almazyad, Saleh Ibrahim Alfawaz, Mohammed Abdul-Aziz Ghaith, Ali A. Alshehri, Mohammed Abdullah Aljaffer, Saleh A. Alghamdi · 2026 · Frontiers in Psychiatry
22. Psilocybin restores behavioral and neuroplastic deficits induced by chronic stress in rats
    Agnieszka Bysiek, Izabela Szpręgiel, Adam Wojtas, Marzena Maćkowiak, Agnieszka Wawrzczak‐Bargieła, Monika Leśkiewicz, Ewa Trojan, Katarzyna Kamińska, Weronika Kumorek, Wiktor Bilecki et al. · 2026 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
23. Population-based prevalence and pharmacotherapy sequences of treatment resistant depression in Germany
    Maximilian Bayas, Jeffrey Auerbach, Bettina Diekamp, Melanie Fomenko, Bernhard Theodor Baune, Jonathan Repple, Andreas Reif, Christine Reif-Leonhard · 2026 · European Neuropsychopharmacology
24. Artificial intelligence and major depression: Toward mechanistic and clinically actionable models
    Filiz Özsoy, Gulay Tasci, Burak Taşçı, Şengül Doğan, Türker Tuncer · 2026 · World Journal of Psychiatry
25. Mitochondria-centered neuroenergetic dysfunction in treatment-resistant depression: A conceptual framework for multi-layer nutritional modulation and serum BDNF as a biomarker of systemic recovery
    Rosalyn Hui Zhang · 2026 · Nutritional Psychiatry
26. Transforming depression research: The role of artificial intelligence and computational modelling
    Simran Suresh Somkuwar, Ujban Hussain, Dimak C. Sahu, Dr. Mohammad Tauqeer Sheikh, Sameer M. Sheikh, Manoj M. Gautam, Satish S. Meshram, Veena Shailendra Belgamwar · 2026 · In Silico Research in Biomedicine
27. Clinical features of acute respiratory viral infections in children in conjunction with pathology of pharyngeal tonsil
    Олександр Іванович Сміян, Євгенія Василівна Дмітрова, Олена Геннадіївна Васильєва · 2015 · ScienceRise
28. Сомparative analysis of clinical and psychopathological symptomatology of depressions resistant and non-resistant to the therapy
    Lyudmyla V. Rakhman, Маріанна Владиславівна Маркова · 2015 · ScienceRise
29. Evaluation of Simultaneous Effect of Lovastatin Plus Fluoxetine on Depression Using Linear Mixed Model with LASSO Penalty
    Marjan Faghih, Hadi Raeisi Shahraki, Ahmad Javid Ghanizadeh, Seyyed Mohhamad Taghi Ayatollahi · 2016 · Global Journal of Health Science
30. Anesthetic Considerations for Deep Brain Stimulation
    Juan Fiorda‐Diaz, Nicoleta Stoicea, Milind S. Deogaonkar, Sergio Daniel Bergese · 2016 · InTech eBooks
31. Changes in anxiety and depression levels after two exercises programs with women attending the Health Academy Program
    Carolina Gabriela Reis Barbosa, Alex Harley Crisp, José Jonas de Oliveira, Anna Gabriela Silva Vilela Ribeiro, Matheus Valério Almeida Oliveira, Rozângela Verlengia · 2022 · Revista Brasileira de Atividade Física & Saúde
32. New Progress in the Treatment of Refractory Depression with Esticketamine
    诗立 孙 · 2022 · Advances in Clinical Medicine
33. Brain stimulation for treatment-resistant depression
    Aluisio Rodrigues, Lisiane Martins, Nivaldo Ribeiro Villela, Laís Boralli Razza, André R. Brunoni · 2023 · Progress in brain research
34. Evaluating the Antidepressant-like Properties of Melatonin and Vitamin D3 Combination in Mice Subjected to Restraint Stress: Investigating the Involvement of Oxidative Stress
    Saeed Mehrzadi, Asieh Hosseini, Shokoufeh Hassani, Fahime Azimirad, Azam Hosseinzadeh · 2023 · Current Drug Therapy
35. Trastornos afectivos, trastornos depresivos y trastorno bipolar
    V.D. Santana Florido, Alberto Rodríguez-Quiroga, D. Mancho Gragera, S. Fernández Rojo · 2023 · Medicine - Programa de Formación Médica Continuada Acreditado
36. Repetitive Transcranial Magnetic Stimulation With and Without Text4Support for the Treatment of Resistant Depression: Protocol for a Patient-Centered Multicenter Randomized Controlled Pilot Trial
    Medard Kofi Adu, Raquel da Luz Dias, Belinda Agyapong, Ejemai Eboreime, Adegboyega Oyekunbi Sapara, Mobolaji A. Lawal, Corina Chew, Karen Diamond Frost, Daniel Li, Michael Flynn et al. · 2023 · JMIR Research Protocols
37. Targeting angiogenesis, inflammation, and oxidative stress in depression
    Ansab Akhtar, Shubham Dwivedi · 2024 · Elsevier eBooks
38. The role of psilocybin in depressive disorders
    Jadwiga Najib · 2024 · Current Medical Research and Opinion
39. SAL0114: a novel deuterated dextromethorphan-bupropion combination with improved antidepressant efficacy and safety profile
    Ying Xiao, Xuefeng Hu, Wei Xing, Jie Yan, Ruhuan Wang, Xiaoqing Li, Jiahuan Li, Zhixin Zhang, Jingchao Sun, J M Wu · 2024 · Frontiers in Pharmacology
40. Physical activity in the treatment-resistant depression and non-remitted depression: a systematic review of randomized controlled trials
    José Etxaniz‐Oses, Nagore Iriarte‐Yoller, Mikel Tous‐Espelosin, Sara Maldonado‐Martín · 2024 · F1000Research
41. A Survey of the Clinical Practice Status of Korean Medicine Doctors for Depression: Preliminary Data on Clinical Practice Guidelines
    Jin-woo Suh, Sang-Ho Kim · 2024 · 대한한의학회지
42. Antidepression and testosterone enhancement potentials of Cucumeropsis mannii, Cucurbita moschata, and Sesamum indicum seed oil extracts
    Reginald Chibueze Ohiri, Benjamin Achor Amadi, Jane Chinaza Favour · 2024 · Avicenna
43. Mental disorder and its treatment as a transformative experience
    Daniel Villiger · 2025 · Phenomenology and the Cognitive Sciences
44. Some aspects of circular depressive disorders pathomorphosis at present
    Н. Г. Пшук, Ірина Сергіївна Потоцька, Oleksandr O. Belov · 2017 · Zaporozhye Medical Journal
45. Resistant depression: criteria for determination, risk factors and therapeutic strategies
    Olena O. Khaustova · 2017 · Psychosomatic Medicine and General Practice
46. Effects of Adjunctive Ketamine Intravenous Infusion in Taiwanese Patients with Treatment-Resistant Depression: Antidepression, Antisuicidality, BDNF Val66Met, and Brain Imaging
    Mu‐Hong Chen, Tung‐Ping Su · 2020 · Springer eBooks
47. Investigation of Diagnostic Proteins by 2D Electrophoresis in Major Depression Model Induced by Forced Swim Test in Rats
    Tuğçe Duman, Enes Akyüz, Huri Bulut, Abdürrahim Koçyiğit, Ahmet Tülek, Ersin Karataş, İsmet Kırpınar · 2020 · Protein and Peptide Letters
48. Neurobiologic correlates of depression: illustration of challenges in bench-to-bedside translation
    Bruce Edward Jones · 2020 · Elsevier eBooks
49. Evidencias clínicas del uso de moduladores de la microbiota intestinal para el tratamiento de trastornos mentales: una revisión bibliográfica sistemática
    Iveth Jimenez-Badilla, Luis Acuña-Amador · 2021 · Psiquiatría Biológica
50. Mental Health Care in Saudi Arabia
    Lamis S. Solaim, Samuel O. Okpaku · 2021 · Springer eBooks
51. Efectos a corto plazo de la estimulación magnética transcraneal repetitiva en pacientes con trastorno depresivo resistente al tratamiento
    Cristina M. González-Chacón · 2022 · PsicoInnova
52. Estigma internalizado em pacientes com transtorno de humor e fatores associados
    Dayane Rosa Alvarenga Silva Gomes · 2019
53. Ovarian hormones mediate the prophylactic efficacy of ( R,S )-ketamine and (2 R ,6 R )-hydroxynorketamine in female mice
    Briana K. Chen, Christina T. LaGamma, Xiaoming Xu, Shi‐Xian Deng, Rebecca A. Brachman, Raymond F. Suckow, Thomas B. Cooper, Donald W. Landry, Christine Ann Denny · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
54. Etude du transfert de cinq radionucléides, Chrome 51, Strontium 85, Césium 137, Manganèse 54, Cobalt 60, à l'huitre Crassostrea gigas Thunberg
    Michel Sacher · 1987
55. Sustained Modulation of Deep Brain Circuits with Focused Ultrasonic Waves
    Taylor D. Webb, Matthew G. Wilson, Henrik Odéen, Jan Kubanek · 2022 · SSRN Electronic Journal
56. Oroxylum indicum Seed Extract as a Potential Antidepressant in Chronic Stress Mouse Model of Depression
    Chorpeth Chalermwongkul, Charinya Khamphukdee, Supawadee Daodee, Orawan Monthakantirat, Chantana Boonyarat, Yutthana Chotritthirong, Juthamart Maneenet, Suresh Awale, Anake Kijjoa, Yaowared Chulikhit · 2023 · Preprints.org
57. Reply to: Toward Enhanced Methodological Rigor: Addressing Limitations in the Comparative Analysis of Probiotics and Antidepressants for Major Depressive Disorder Management
    Shilin Zhao, Jun Tao, Suisha Liang, Hein Min Tun · 2024 · Nutrition Reviews
58. Psychotherapeutic treatments for depression in older adults
    Ang, Lin, Lee, Myeong Soo, Song, Eunhye, Lee, Hye Won, Cao, Liujiao, Zhang, Jingyi, Wang, Qi, Jung, Jeeyoun, Jang, Soobin, Gastaldon, Chiara et al. · 2024 · Cochrane Database of Systematic Reviews
59. Toolbox: Psychotropic medications for augmentation or combination in treatment-resistant depression
    Audrey Ng · 2014 · Mental Health Clinician
60. Stimulant Medication Addition to Antidepressant in an Adolescent with Difficult to Treat Depression
    Tresha A. Gibbs, Ainah Tan, J. Rebecca Weis, Discussant Barbara J. Coffey · 2012 · Journal of Child and Adolescent Psychopharmacology
61. ANTIDEPRESSANT ACTIVITY OF MOOD STABILIZERS
    JANUSZ K. RYBAKOWSKI · 2012
62. In Silico-Guided Design of Novel-Scaffold Therapeutics Targeting the Dopamine D3 Receptor
    Debesai Gaim Hailemicael · 2014
63. Electroconvulsive Therapy Use among Depressive Inpatients : Position Statement
    Moawia Eid · 2016 · Middle East Journal of Nursing
64. Commentary to “Patients not patents: drug research and development as a public enterprise”
    Gerard Marshall Raj · 2017 · European Journal of Clinical Investigation
65. Enrichment of gene variants associated with treatable genetic disorders in psychiatric populations
    Venuja Sriretnakumar, Ricardo Harripaul, John B. Vincent, James L. Kennedy, Joyce So · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
66. Analysis of rat brain lipids and metabolites after antidepressant drug treatment
    Estabraq Jaddoa · 2018 · DMU Open Research Archive (De Montfort University)
67. Transition of depression from childhood to adulthood: What causes it and how does it remains?
    Roberto Grujičić, Milica M. Pejovic-Milovancevic, Čedo Miljević · 2018 · Engrami
68. Investigations of the Activity of Phenobarbitone in Mice Models of Depression
    Faruk Faruk, Mohammed Garba Magaji, Rabiu Abdussalam Magaji, Yusuf Yusha’u, Abubakar Sani Buba, Muhammad Umar · 2022 · Jewel Journal of Medical Sciences
69. O papel de processos autofágicos nos efeitos comportamentais desencadeados pelo tratamento com canabinóides em animais cronicamente estressados
    Eduardo Junji Fusse · 2019
70. The Role of Supplements in Treatment of Depression
    Seyed Mostafa Mansouripour, Dharmendra Kumar · 2020
71. Characterizing Suicidal Ideation in Treatment-Resistant Depression Using Neuroimaging
    Patricia Burhunduli · 2020 · uO Research (University of Ottawa)
72. Boîte à outil translationnelle du psychiatre face aux situations de résistances et complexes
    Ali Amad · 2018 · French Journal of Psychiatry
73. Chronic Stress Induces Specific Cellular and Morphological Astroglial Changes Associated with Depressive-like Phenotypes
    Dipashree Chatterjee · 2019 · TSpace (University of Toronto)
74. Recent Advances in the Synthesis of the Antidepressant Paroxetine
    Joana Santos, M. Fernanda R. P. Proença, Ana João Rodrigues, Patrícia Patrício, Helena Sofia Domingues · 2020 · Current Medicinal Chemistry
75. Estimulación cerebral profunda en el núcleo accumbens en pacientes con depresión resistente al tratamiento: Reporte de Casos
    Bernardo Pérez V, Daisy Chicaíza G, Alma Montoya L, Sandra Saldaña C, Cesar González C, Adriana Serrano R, Andrea Otero O · 2020 · Revista chilena de neuro-psiquiatría
76. ОСОБЛИВОСТІ ПСИХОПАТОЛОГІЧНОЇ СИМПТОМАТИКИ У ХВОРИХ ІЗ ДЕПРЕСИВНИМИ РОЗЛАДАМИ
    Oleksandr Belov · 2021 · Bulletin Of Medical And Biological Research
77. Remus: System for Remote Deep Brain Interventions
    Taylor D. Webb, Matthew G. Wilson, Henrik Odéen, Jan Kubanek · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
78. Using Early Changes in Cognition to Predict Response to 8-week Vortioxetine Treatment in Patients with Major Depressive Disorder
    Caroline Park · 2019 · TSpace (University of Toronto)
79. Comparative evaluation of anti-depressant effects of Citalopram, Ketamine and their combination in animal models of depression: A potential anti-depressant?
    Salim Sheikh, Sonone Pankaj, Verma Veena, Chakra Dhar Tripathi, Karim Bushra Ahmed, Girish Gulab Meshram · 2021 · Open Journal of Pharmacology and Pharmacotherapeutics
80. Incorporating Religion into Therapy to Better Treat Depression
    Jacob Tubbs · 2019 · ScholarsArchive (Brigham Young University)
81. Some Predictors of Depressive Disorders in the Context of Clinical Patomorphosis
    Oleksandr O. Belov · 2021 · Ukraïnsʹkij žurnal medicini bìologìï ta sportu
82. Emerging approaches to the treatment of depression in patients with cardiovascular disease
    Marlies E Alvarenga, Barbara Mary Murphy, Alun Conrad Jackson · 2021 · British Journal of Cardiac Nursing
83. Remote targeted electrical stimulation
    Rahul Cheeniyil, Jan Kubanek · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
84. Health care resource use, short-term disability days, and costs associated with states of persistence on antidepressant lines of therapy
    Dominic Pilon, Swapna U. Karkare, Maryia Zhdanava, John J. Sheehan, Aurélie Côté‐Sergent, Aditi Shah, Oliver J. Lopena, Patrick Lefèbvre, Kruti Joshi, Leslie Citrome · 2021 · Journal of Medical Economics
85. NAc-DBS corrects depression-like behaviors in CUMS mouse model via disinhibition of DA neurons in the VTA
    Nan Song, Gao Yan, Lu Shanshan, Shenglian Yang, Chao Yuan, Sun Wenyu · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
86. Medical education in Europe and North America; some comparisons.
    R R STRUTHERS · 1955 · Europe PMC (PubMed Central)
87. Neurotransmitter Transporters and Their Role in the Pharmacological Actions of Therapeutic and Abused Drugs
    Nikki J. Clauss, Lynette C. Daws · 2021 · Elsevier eBooks
88. The Explanation of Disordered Eating: A Metatheoretical Approach
    Hannah Hawkins-Elder · 2021
89. R- and S-ketamine abrogate lipopolysaccharide-induced depressive-like behavior through microglial modulation: a differential anti-inflammatory and neurotrophic effect of the enantiomers
    Adriano Chaves Filho, Deniele Bezerra Lós, Michele Verde-Ramo Soares, Paloma Marinho Jucá, Tatiana de Queiroz, Francisco Eliclécio Rodrigues da Silva, Karina Saraiva, Amanda De Almeida Silva, Francisco Vinícius Clemente Serra Azul, Luzia Kalyne Almeida Moreira Leal et al. · 2022 · Research Square
90. R- and S-ketamine abrogate lipopolysaccharide-induced depressive-like behavior through microglial modulation: a differential anti-inflammatory and neurotrophic effect of the enantiomers
    Adriano José Maia Chaves Filho, Deniele Bezerra Lós, Michelle Lima Soares, Paloma Marinho Jucá, Tatiana de Queiroz, Francisco Eliclécio Rodrigues, Karina Saraiva, Amanda Karolina Silva, Francisco Vinícius Clemente Serra Azul, Luzia Kalyne Almeida Moreira Leal et al. · 2022 · Research Square
91. Role of Bioactive Components in Psychosomatic Disorders
    Bushra Shaida, Shaista Arzoo · 2022 · Springer eBooks
92. A Novel Localized Tracing Technique to Explore Intra-Amygdala Functional and Structural Connectivity Patterns as Mediators of Individual Variability in Stress Response
    Allie B. Lipshutz, Victoria Saltz, Kristin R Anderson, Alessia Manganaro, Dani Dumitriu · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
93. Into the Wild: Reflecting on Neuroethics as Innovation Moves from the Laboratory to Society
    Diana Saville, Albert Kim, Juan Enriquez, Karen S. Rommelfanger, Michael E. McCullough, Calvin Nguyen, Abraham Dada · 2023 · Springer eBooks
94. The psychedelic renaissance: can psilocybin possibly combat depression?
    Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh · 2022 · International Journal of Surgery Global Health
95. Therapeutisches Drug Monitoring und Bedside Genotyping
    Georgios Schoretsanitis, Michael Paulzen · 2022 · Springer eBooks
96. Investigation of Antidepressant Potential of Methanolic Leaf Extract of Manilkara zapota in Experimental Animal Models
    K Soujanya, Powar Rajeeya Satish, R Achala S Prabhu, Naik Durga Umesh, K Suchitha, Ravi Kumar · 2023 · International Journal of Pharmaceutical Sciences Review and Research
97. Interventions for Changing Brain Function in Clinical Disorders
    Meng Yuan, Qingjun Zhu · 2023 · Highlights in Science Engineering and Technology
98. Longitudinal Trajectories of Symptom Change During Antidepressant Treatment Among Managed Care Patients with Co-Occurring Depression and Anxiety
    Judith Cukor, Zhenxing Xu, Veer Vekaria, Fei Wang, Mark Olfson, Samprit Banerjee, Gregory E. Simon, George S. Alexopoulos, Jyotishman Pathak · 2023 · medRxiv
99. Anticancer, anti-inflammatory, and apoptotic activities of MAT20, a poly-herbal formulation.
    Mukul Kashyap Jha, Rai Banerjee, Pooja Vijaykumar Kasture, Shambhavi Prasad, Jyothsna Rao, Gururaj A. Rao · 2022 · Journal of Emerging Investigators
100. O DHEA(S) está causalmente associado a depressão? Um estudo de Randomização Mendeliana
     Luis Henrique Souza‐Teodoro · 2023